Essential Therapeutics (ETRX) formerly Microcide (MCDE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (313)	11/14/2000 12:33:33 PM
From: scaram(o)uche	Read Replies (1) of 415

Sort of strange.... I thought that Kornberg was on the Board at XOMA? Maybe ICOS too? No, it's not the reason for the weakness. Preclinical targets like this are almost dime/dozen. Not saying that it's not a good project.... it's just that many companies are looking for, and finding, bacterial essential genes. Lots and lots of avenues for upside at MCDE -- fungal, efflux pump inhibitors, Iconix, Iconix collaborations, etc. The swoon is due to questions concerning the MRSA cephalosporin, but there's still nice upside from one of the two molecules -- maybe some from each. They're fighting to remain independent. I really like these guys, but it's been a tough road. I was buying yesterday.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next